---
$id: https://graph.org.ai/products/commodity/51172176
$type: Product
source: UNSPSC
code: "51172176"
title: "Moxaverine hydrochloride"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Moxaverine hydrochloride

**UNSPSC Code**: 51172176
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent C20H21NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6R0I0E99CN, chemically known as 1-benzyl-6,7-dimethoxy-3-ethylisoquinoline hydrochloride, but more generally known as moxaverine hydrochloride, which bears US NIH Compound Identifier 70881. European Medicines Agency schedules Moxaverine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03341MIG. Most nations, for tariff and trade purposes, schedule moxaverine hydrochloride under HS 29334990 and SITC 51575. As of Q4 2014, MOXAVERINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CCC1CC2CC(C(CC2C(N1)CC3CCCCC3)OC)OC.CL.

